The Asian Scientist 100
Can Li
Institution
University of Hong Kong
Country
Hong Kong
Field
Engineering
Li is a recipient of the 2023 Croucher Tak Wah Mak Innovation Award for his research exploring the limitations of digital computers in performing tasks accomplished by the human brain, including recognising faces, reasoning based on vague information, and learning from experience.
(Photo: University of Hong Kong)
AWARDS
- 2023 Croucher Tak Wah Mak Innovation Award
Related articles
Study: Chinese Herb Dihydromyricetin Stops Hangovers, Alcohol Dependency In Rats
UCLA researchers have shown that an ancient Chinese herbal drug stops hangovers and reduces alcohol dependency in rats.
Australia, New Zealand Are World’s Largest Users Of Cannabis & Amphetamines
Australia and New Zealand have the highest rates of cannabis and amphetamine use in the world, according to comprehensive research on illicit drug use.
Sinovac: Phase III Clinical Trial For Hand, Foot And Mouth Disease Vaccine
Chinese biopharmaceutical company Sinovac Biotech Ltd. has begun the Phase III clinical trial for its proprietary inactivated EV71 vaccine against hand, foot and mouth disease (HFMD).
Nepal’s Monsanto Seed Sovereignty Debate Highlights Need For Home-Grown Solutions
An effort by U.S. donors and Monsanto to partner with Nepal to boost local maize production with imported hybrid seeds has met civil society opposition calling - instead - for home-grown solutions.
World’s Tiniest Frog, Paedophryne Amauensis, Found In Papua New Guinea
Researchers have found two new frog species in New Guinea, one of which is the new smallest known vertebrate on Earth.
Australian Study To Assess Sativex As Cannabis Withdrawal Drug
Researchers are studying whether the pharmaceutical drug Sativex - registered for pain relief in multiple sclerosis patients - can help people better manage cannabis withdrawal symptoms as well.
Use Of Acupuncture By The U.S. Military To Treat Battlefield Injuries, PTSD
The United States Armed Forces is incorporating acupuncture, one of the oldest healing practices in the world, to assist in the medical care of its personnel.
SFJ Pharma To Conduct Phase III Trial Of Pfizer’s Axitinib Adjuvant Treatment In Asia
SFJ Pharma Ltd. will conduct a Phase III clinical trial in Asia of Pfizer's axitinib for the adjuvant treatment of patients at high risk of recurrent renal cell carcinoma following nephrectomy.
New Sugar-Based Treatment For Type 1 Diabetes Found
Researchers from The Australian National University have discovered a new treatment for Type-1 diabetes based on a sugar called heparan sulfate.









